Almujtama Alraida Medical Co (9592) Fair Value & Analysis
Healthcare · SA · Market cap 217M SAR
Fair value as of: Aug 1, 2026
From 23 valuation models · updated today
Share price +2.6% over the past month.
What matters now
- The price sits above even our optimistic bull case (18.77 SAR). The favourable scenario is already priced in.
- Solid but not exceptional quality (47/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (12 months)
12‑month range 22.00 SAR – 32.63 SAR · fair‑value band 13.25 SAR – 18.77 SAR · the 22.89 SAR price screens above the 15.02 SAR fair value. As of Aug 1, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Almujtama Alraida Medical Co (9592) currently trades at 22.89 SAR, while our model-based Fair Value estimate is 15.02 SAR, implying the stock looks roughly 34.4% overvalued today. We read business quality at 47/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Net debt stands at 168M SAR. The stock trades on a trailing P/E of 26.0. Fundamentals as of Aug 1, 2026
Our scenario range runs from 13.25 SAR (bear case) to 18.77 SAR (bull case); at 22.89 SAR, the current price sits above that range. The share trades about 31% below its 52-week high and 6% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 37% fair-value upside, at -34%, 9592 screens richer than that median.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 1, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Almujtama Alraida Medical Co. operates pharmacies in Saudi Arabia. The company provides pharmaceutical services; and a magazine related to medical and pharmaceutical health field. It also offers its products through online. The company was founded in 2001 and is based in Jeddah, Saudi Arabia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Almujtama Alraida Medical Co reported revenue of 455M SAR in FY2025 versus 304M SAR in FY2021, a compound +10.5%/yr. Reported net income was 8.4M SAR in FY2025, compounding +1.8%/yr from FY2021.
Is 9592 fairly valued? → Check now
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate (as of Aug 1, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| JD Health International Inc JDHIY | $4.55 | $8.78 | +93% |
| Alibaba Health Information Technology Limited ALBBY | $8.27 | $6.61 | -20% |
| Raia Drogasil S.A RADL3 | R$16.79 | R$20.39 | +21% |
| Yifeng Pharmacy Chain Co 603939 | ¥19.75 | ¥40.59 | +106% |
| Clicks Group CLCGY | $27.97 | $34.29 | +23% |
| Sugi Holdings SGIPF | $16.29 | $32.19 | +98% |
| Corporativo Fragua, S.A. CGSBF | $29.66 | $40.69 | +37% |
| DaShenLin Pharmaceutical Group 603233 | ¥16.68 | ¥19.21 | +15% |
| LBX Pharmacy Chain Joint Stock Company 603883 | ¥11.74 | ¥10.57 | -10% |
| Redcare Pharmacy NV SHPPF | $64.80 | $143.56 | +122% |
Compare Almujtama Alraida Medical Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Almujtama Alraida Medical Co (9592) overvalued or undervalued?
What is the fair value of 9592?
What is the quality score of 9592?
What is the net profit margin of 9592?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Almujtama Alraida Medical Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.